NDC 65162-698-39 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65162-698
- Requested NDC
- 65162-698-39
- Package NDCs from labels
- 65162-698-90, 65162-698-39, 65162-698-54
- Manufacturer
- Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC
- Effective date
- 2025-05-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | 2025-05-13 | HUMAN PRESCRIPTION DRUG LABEL |
| Gabapentin - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2023-04-12 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65162-698-39 | Gabapentin | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 28 | |
| 65162-698-54 | Gabapentin | 50 in 1 CARTON | SOLUTION | 50 | 28 | |
| 65162-698-90 | Gabapentin | 473 mL in 1 BOTTLE | SOLUTION | 473 | 28 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65162-698-90 | ML - Milliliter | 65162-698 | 781d1576-35f2-4340-9bb7-8435d1507cd5 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| GABAPENTIN | ACTIVE INGREDIENT | 6CW7F3G59X | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| GABAPENTIN | ACTIVE MOIETY | 6CW7F3G59X | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| ACESULFAME POTASSIUM | INACTIVE INGREDIENT | 23OV73Q5G9 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | INACTIVE INGREDIENT | K679OBS311 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GABAPENTIN SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b7a29b99-ce23-950e-e053-2995a90a1934 | 2026-06-09 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Coupler LLC | 5385e27c-f2fa-32d5-e063-6294a90a0a8c | 2026-06-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| REFRESH CELLUVISC | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | b32ed9e8-d091-4f16-b416-5a62cdfee49a | 2026-06-05 | Warnings | K679OBS311 |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 07f07d15-ee91-8c2a-e063-6394a90a4624 | 2026-06-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | b2da7d96-73ad-4f44-8784-160a384a0961 | 2026-06-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | f93eaa4f-cc1a-10ab-e053-6394a90a5ffc | 2026-06-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | f8998c1c-c359-6f01-e053-6294a90aebf4 | 2026-06-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | Proficient Rx LP | c7674ea5-276b-4bb3-821b-4ac05c9e64e6 | 2026-06-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| C-More Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | PROFOUND NUTRITION LIMITED | 78f04ecb-da5e-468c-81fe-70f7c26b76c2 | 2026-06-01 | Warnings | K679OBS311 |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals LLC | 507bf6d0-e7a2-413d-9848-cd2445a1411d | 2026-05-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Laurus Labs Limited | 07aa1bcc-df05-44fa-92d4-63894e0e6cd6 | 2026-05-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 03031adf-d36b-45ec-944e-dfce5a5de91a | 2026-05-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Pangea Pharmaceuticals, LLC | 5eff7ad8-0d31-4372-82a2-ac9f549d8796 | 2026-05-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 397fd6d3-317b-4b61-a52b-3a09ca1d88a4 | 2026-05-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 13640281-26b4-402e-8f69-7c81cd6e0376 | 2026-05-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Amici Pharma, Inc. | 1ea83c18-7107-41f4-8305-62725c1c45c8 | 2026-05-19 | Warnings, Adverse reactions | 6CW7F3G59X |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | d4f21e97-5e55-44c9-9b31-5f79ac2eb512 | 2026-05-18 | Warnings, Adverse reactions | 6CW7F3G59X |
| Neurontin | GABAPENTIN | Viatris Specialty LLC | 97935fd9-1d4a-43b6-a5d9-de994591187b | 2026-05-12 | Warnings, Adverse reactions | 283523 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | eeb19a5a-b31d-4df8-9546-0b2b5eb5db07 | 2026-05-07 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.